Under the corporate philosophy
of 'Otsuka - people creating new products
for better health worldwide,' Otsuka Pharmaceutical
Co., Ltd. is engaged in the production and
sale of innovative, creative pharmaceuticals,
nutritional products, and cosmetics, aiming
to be a global value-creating company that
contributes to the health and wellness of
people worldwide.
|
|
 |
Contraindications:
Patients with hemorrhage (e.g. hemophilia, increased
capillary fragility, intracranial hemorrhage,
hemorrhage in the digestive tract, hemorrhage
in the urinary tract, hemoptysis, and hemorrhage
in the vitreous body) (Bleeding tendency may
be increased.) Patients with congestive heart
failure (Condition may be worsened.) |
Patients with
history of hypersensitivity to any of ingrediens
of the drug.
Women who are pregnant or may possibly become
pregnant.
read
more >> |
 |
Relief of dyspnea
and other symptoms caused by respiratory obstructive
disturbance in the following diseases: bronchial
asthma, chronic bronchitis, and pulmonary
emphysema.
read
more >> |
 |
Aminoleban
is indicated for the treatment of Hepatic
Encephalopathy in patients with acute and
chronic liver disease.
Aminoleban is beneficial in patients under
hypercatabolic state such as, surgery, trauma,
sepsis and burns with evidence of |
negative
nitrogen balance, which largely owing to an
increase net rate of skeletal muscle breakdown.
read
more >> |
 |
Indicated for
the treatment of gastric mucosal lesions (erosions,
bleeding, redness, and edema) in the following
conditions: acute gastritis and acute exacerbation
of chronic gastritis:
|
| The usual adult
dosage of Mucosta ® Tablet is one tablet
(100 mg) orally three times daily. Gastric ulcers:
The usual adult dosage of Mucosta ® Tablet
is one tablet (100 mg) orally three times daily,
in the morning, in the evening and before bed. |
| |
|
 |
Firebird comes
stent and anti-restenosis agents. Stents sustain
the lesion by mechanical function, while the
drug imbedded in a thin polymer release to
resist in-stent restenosis.
|
| |
|
 |
ABILIFY®
(aripiprazole) is a prescription medicine
indicated for: the treatment of acute manic
and mixed episodes associated with Bipolar
I Disorder, maintaining efficacy in patients
with bipolar disorder with a recent manic
or mixed episode who had been stabilized and
then maintained for at least 6 weeks. |
| |
read
more >> |
|
.gif){kind=small}